Westfield Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,142,913
Closed -$73.2M 284
2018
Q4
$73.2M Sell
1,142,913
-232,753
-17% -$17.2M 0.62% 61
2018
Q3
$123M Sell
1,375,666
-29,477
-2% -$2.6M 0.86% 27
2018
Q2
$112M Sell
1,405,143
-70,116
-5% -$5.82M 0.83% 31
2018
Q1
$132M Buy
1,475,259
+361,680
+32% +$34.7M 1.01% 22
2017
Q4
$116M Sell
1,113,579
-248,845
-18% -$28.1M 0.89% 24
2017
Q3
$199M Buy
1,362,424
+47,598
+4% +$6.48M 1.53% 6
2017
Q2
$171M Sell
1,314,826
-88,501
-6% -$10.8M 1.46% 7
2017
Q1
$175M Sell
1,403,327
-39,441
-3% -$4.72M 1.5% 8
2016
Q4
$167M Sell
1,442,768
-102,453
-7% -$11.4M 1.46% 4
2016
Q3
$162M Sell
1,545,221
-75,652
-5% -$8.19M 1.3% 15
2016
Q2
$160M Sell
1,620,873
-262,962
-14% -$27.2M 1.32% 12
2016
Q1
$189M Sell
1,883,835
-399,116
-17% -$41.1M 1.43% 13
2015
Q4
$273M Sell
2,282,951
-113,869
-5% -$13.2M 1.84% 3
2015
Q3
$259M Sell
2,396,820
-138,093
-5% -$17.1M 1.84% 5
2015
Q2
$293M Sell
2,534,913
-888,158
-26% -$102M 1.79% 6
2015
Q1
$395M Sell
3,423,071
-69,246
-2% -$8.27M 2.27% 3
2014
Q4
$391M Sell
3,492,317
-350,166
-9% -$36.9M 2.3% 2
2014
Q3
$364M Sell
3,842,483
-241,800
-6% -$21.8M 2.22% 3
2014
Q2
$351M Sell
4,084,283
-216,665
-5% -$16.5M 2.09% 3
2014
Q1
$300M Sell
4,300,948
-87,956
-2% -$6.97M 1.8% 4
2013
Q4
$371M Sell
4,388,904
-122,954
-3% -$9.73M 2.18% 2
2013
Q3
$348M Sell
4,511,858
-147,830
-3% -$10.4M 2.22% 2
2013
Q2
$273M Buy
+4,659,688
New +$280M 1.87% 3

Other funds holding CELG

Westfield Capital Management's CELG Position: Q1 2019 in Review

Westfield Capital Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 1,142,913 shares — an estimated $73.2M sold.

Westfield Capital Management first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $395M in Q1 2015. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Westfield Capital Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Westfield Capital Management sold 1,142,913 Celgene Corp shares in Q1 2019, an estimated $73.2M.
  • Westfield Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Westfield Capital Management's Celgene Corp position peaked at $395M in Q1 2015.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Westfield Capital Management's 13F filing for Q1 2019, filed 14 May 2019.